We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+18.53%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$1.06B
AUM Growth
+$54.1M
Cap. Flow
-$57.6M
Cap. Flow %
-5.46%
Top 10 Hldgs %
34.88%
Holding
95
New
10
Increased
31
Reduced
41
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$29.7M
2
ELV icon
Elevance Health
ELV
+$28.1M
3
BDX icon
Becton Dickinson
BDX
+$27.8M
4
PEN icon
Penumbra
PEN
+$10.8M
5
MRK icon
Merck
MRK
+$8.75M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$22.7M
2
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$18.7M
3
HUM icon
Humana
HUM
+$17.9M
4
LLY icon
Eli Lilly
LLY
+$17M
5
PFE icon
Pfizer
PFE
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 99.69%
2 Industrials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
76
Relay Therapeutics
RLAY
$4.38B
$1.91M 0.18%
230,000
-160,000
-41% -$1.56M
IGMS
77
DELISTED
IGM Biosciences
IGMS
$1.88M 0.18%
195,000
-5,000
-3% -$57.9K
BRKR icon
78
Bruker
BRKR
$8.71B
$1.88M 0.18%
20,000
+4,000
+25% +$322K
TGTX icon
79
TG Therapeutics
TGTX
$7.65B
$1.88M 0.18%
123,500
-36,500
-23% -$581K
NTLA icon
80
Intellia Therapeutics
NTLA
$1.67B
$1.32M 0.13%
48,000
-2,000
-4% -$55.6K
AMGN icon
81
Amgen
AMGN
$224B
$1.21M 0.11%
4,250
-250
-6% -$73.2K
TECH icon
82
Bio-Techne
TECH
$11.2B
$1.13M 0.11%
16,000
– –
ACHC icon
83
Acadia Healthcare
ACHC
$2.89B
$1M 0.09%
12,624
-6,000
-32% -$491K
RGEN icon
84
Repligen
RGEN
$9.37B
$920K 0.09%
5,000
-5,000
-50% -$952K
CVS icon
85
CVS Health
CVS
$119B
– –
-137,500
Closed -$10.9M
EVH icon
86
Evolent Health
EVH
$461M
– –
-230,000
Closed -$7.6M
HCAT icon
87
Health Catalyst
HCAT
$136M
– –
-300,000
Closed -$2.78M
HUM icon
88
Humana
HUM
$45.1B
– –
-39,083
Closed -$17.9M
LH icon
89
Labcorp
LH
$26.2B
– –
-15,000
Closed -$3.41M
LNTH icon
90
Lantheus
LNTH
$6.57B
– –
-40,000
Closed -$2.48M
LUNG icon
91
Pulmonx
LUNG
$99.2M
– –
-25,000
Closed -$319K
MGTX icon
92
MeiraGTx Holdings
MGTX
$1.21B
– –
-32,091
Closed -$225K
PFE icon
93
Pfizer
PFE
$152B
– –
-580,000
Closed -$16.7M
WST icon
94
West Pharmaceutical
WST
$24.8B
– –
-9,000
Closed -$3.17M
AXNX
95
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-220,000
Closed -$13.7M
1 2 3
4

Similar funds

ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return
AF
Ally Financial Detroit, Michigan $804M AUM 0.18% 1-Year Est. Return

Rhenman & Partners Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Rhenman & Partners Asset Management held 95 positions worth $1.06B, up 5.4% from $1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $57.6M in Q1 2024, closing 11 positions and reducing 41 holdings. Its most notable exit was Humana, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Industrials.

Against the trend, Rhenman & Partners Asset Management opened a new position in Becton Dickinson worth $28.7M.

  • Rhenman & Partners Asset Management's largest Q1 2024 buy was Becton Dickinson: 116,000 shares worth $28.7M.
  • Rhenman & Partners Asset Management added most to Cigna in Q1 2024, an estimated $29.7M increase.
  • Rhenman & Partners Asset Management's biggest Q1 2024 reduction was Medtronic, cutting an estimated $22.7M.
  • Rhenman & Partners Asset Management fully exited Humana in Q1 2024, selling an estimated $17.9M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 35% of its $1.06B portfolio in Q1 2024.
  • Rhenman & Partners Asset Management opened 10 new positions and closed 11 in Q1 2024.
  • Rhenman & Partners Asset Management's portfolio value rose 5.4% quarter-over-quarter to $1.06B.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2024, filed 14 May 2024.